BioCentury
ARTICLE | Clinical News

FDA warns of symptom worsening after stopping Gilenya treatment

November 30, 2018 6:25 PM UTC

FDA added a warning to the label of multiple sclerosis drug Gilenya fingolimod from Novartis AG (NYSE:NVS; SIX:NOVN) saying that patients who stop treatment could experience worsening of symptoms...

BCIQ Company Profiles

Novartis AG